Macy Goldbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Macy Goldbach has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Julia Tchou
Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
9 shared publications Laura Burkbauer
Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, USA
7 shared publicationsLuke Keele
Division of Epidemiology and Biostatistics, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, USA
5 shared publicationsAustin D. Williams
Department of Surgery, Lankenau Medical Center, Wynnewood, USA
3 shared publicationsJami Rothman
Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publicationsRachel Jankowitz
Rena Rowan Breast Center, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publications
Latest Publications
- Open Access
- 21 December 2024
- Published by Wiley in Obesity Science & Practice
- Vol. 10 (6) , e70023
The Group‐basEd Telehealth behavioral WEight Loss Program Among Breast Cancer Survivors: A Pilot and Feasibility Study
Objective: Obesity is related to the recurrence of breast cancer. In‐person groups or individual telephone counseling currently comprise the behavioral weight loss (BWL) programs tested for cancer survivors. Group support via telehealth may be convenient and provide support from fellow survivors, but feasibility, acceptability, and efficacy testing are needed.Methods: A single‐arm, 6‐month BWL program was conducted for female breast cancer survivors with an ECOG performance 0 or 1, BMI > 25 kg/m2, and > 6 months from completion of adjuvant chemotherapy and/or radiation treatment. Participants attended 22 video group sessions over 6 months, completing acceptability ratings, weight measurements, Patient Health Questionnaire (PHQ‐9), City of Hope Breast Cancer Quality of Life Scale (QOL), and International Physical Activity Questionnaire. Changes in survey scores and weight (last‐observation carried forward) and differences in outcomes by patients' race were computed with paired t‐tests, ANCOVAs and Chi‐square tests.Results: Twenty‐one (5 Black, 15 White, 1 Asian American; Mean (SD) = 60.7 (11.6) years; BMI 33.1 (5.9) kg/m2) survivors enrolled with 90% retention and 81.3% of sessions attended. Acceptability ratings were high (all > 4 on a five‐point scale). Mean (SD) weight loss was 5.9% (5.2%), with 60% losing ≥ 5% of baseline weight; White participants lost 7.5% and Black participants lost 1.9% (p = 0.04). Significant improvements were observed in mood (PHQ‐9; p = 0.01) and physical wellbeing QOL (p = 0.01). Physical activity did not change.Conclusion: This telehealth group BWL program was feasible and acceptable for breast cancer survivors, yielding a clinically significant weight loss. Future studies should test this intervention in larger, more diverse samples.Trail Registration: ClinicalTrials.gov identifier: NCT04855552, posted April 22, 2021
- 21 December 2024
- Published by Wiley in Obesity Science & Practice
- Vol. 10 (6) , e70023
Open AccessThe Group‐basEd Telehealth behavioral WEight Loss Program Among Breast Cancer Survivors: A Pilot and Feasibility Study
Objective: Obesity is related to the recurrence of breast cancer. In‐person groups or individual telephone counseling currently comprise the behavioral weight loss (BWL) programs tested for cancer survivors. Group support via telehealth may be convenient and provide support from fellow survivors, but feasibility, acceptability, and efficacy testing are needed.Methods: A single‐arm, 6‐month BWL program was conducted for female breast cancer survivors with an ECOG performance 0 or 1, BMI > 25 kg/m2, and > 6 months from completion of adjuvant chemotherapy and/or radiation treatment. Participants attended 22 video group sessions over 6 months, completing acceptability ratings, weight measurements, Patient Health Questionnaire (PHQ‐9), City of Hope Breast Cancer Quality of Life Scale (QOL), and International Physical Activity Questionnaire. Changes in survey scores and weight (last‐observation carried forward) and differences in outcomes by patients' race were computed with paired t‐tests, ANCOVAs and Chi‐square tests.Results: Twenty‐one (5 Black, 15 White, 1 Asian American; Mean (SD) = 60.7 (11.6) years; BMI 33.1 (5.9) kg/m2) survivors enrolled with 90% retention and 81.3% of sessions attended. Acceptability ratings were high (all > 4 on a five‐point scale). Mean (SD) weight loss was 5.9% (5.2%), with 60% losing ≥ 5% of baseline weight; White participants lost 7.5% and Black participants lost 1.9% (p = 0.04). Significant improvements were observed in mood (PHQ‐9; p = 0.01) and physical wellbeing QOL (p = 0.01). Physical activity did not change.Conclusion: This telehealth group BWL program was feasible and acceptable for breast cancer survivors, yielding a clinically significant weight loss. Future studies should test this intervention in larger, more diverse samples.Trail Registration: ClinicalTrials.gov identifier: NCT04855552, posted April 22, 2021
- 28 April 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4091
ASO Visual Abstract: Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
- 28 April 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4091
ASO Visual Abstract: Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
- 31 March 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4089-4090
ASO Author Reflections: Does Use of Preoperative MRI Reduce Reexcision Rate in Patients with TNBC? Maybe, But It Is Complicated
- 31 March 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4089-4090
ASO Author Reflections: Does Use of Preoperative MRI Reduce Reexcision Rate in Patients with TNBC? Maybe, But It Is Complicated
- 18 March 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4079-4088
Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
Results of an earlier retrospective study from our institution suggested that patients with triple negative breast cancer (TNBC) who had preoperative MRI m
- 18 March 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4079-4088
Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
Results of an earlier retrospective study from our institution suggested that patients with triple negative breast cancer (TNBC) who had preoperative MRI m
- 24 July 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 8663-8664
ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis
- 24 July 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 8663-8664
ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9–27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)—An NCDB Analysis
- 15 July 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (S3) , 888
Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
- 15 July 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (S3) , 888
Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
- 14 June 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 8651-8662
Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
National medical/surgical organizations have recommended the use of neoadjuvant endocrine therapy (NET) to bridge surgery delay of weeks to months for pati
- 14 June 2021
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 8651-8662
Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
National medical/surgical organizations have recommended the use of neoadjuvant endocrine therapy (NET) to bridge surgery delay of weeks to months for pati
- Open Access
- 1 October 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (4) , S38-S39
Obesity and Prognosis in Triple Negative Breast Cancer
Obesity is an independent risk factor for disease recurrence and death in breast cancer. Growing evidence demonstrates that women with obesity are at increased risk of triple negative breast cancer (TNBC), a breast cancer subtype notable for aggressive biology and poor prognosis. It is less clearly established whether there is an association between obesity and BMI within TNBC. Therefore, we aimed to examine whether BMI was associated with disease-free (DFS) and overall survival (OS) in patients with TNBC.
- 1 October 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (4) , S38-S39
Open AccessObesity and Prognosis in Triple Negative Breast Cancer
Obesity is an independent risk factor for disease recurrence and death in breast cancer. Growing evidence demonstrates that women with obesity are at increased risk of triple negative breast cancer (TNBC), a breast cancer subtype notable for aggressive biology and poor prognosis. It is less clearly established whether there is an association between obesity and BMI within TNBC. Therefore, we aimed to examine whether BMI was associated with disease-free (DFS) and overall survival (OS) in patients with TNBC.